Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by RazeKreationson May 03, 2022 6:21pm
163 Views
Post# 34652984

RE:RE:RE:One trade today

RE:RE:RE:One trade today[ Wizz you are correct in your analysis Uprades are still coming together, then then proving to customers that the orders can be fulfilled in a timely manner will bring the big orders. Last year there were not many surprises with each quarters releases because of all the announcements before each release. This year may be a little different. I think Q2 will be status quo, another record breaker and Q3 will be the beginning of the substantial customer growth with Q4 being the blockbuster. IMO quote=wizzdumb]Q2 and Q3 will quietly continue the record streak. Q4 will wake up those who have been sleeping. We may get some announcements on significant VTM deals outside of Ontario but it is QAPs partnerships with major diagnostics companies that will move the needle. They are not going to announce every new order or deal going forward, only the big material ones, Cameron made that clear in Q1 call. Keep picking at the cheap shares while you have the chance, the silence wont last much longer. 
[/quote]

<< Previous
Bullboard Posts
Next >>